Internal medicine

Receptor

Growth factor receptor

Tyrosine-kinase inhibitor

Epidermal growth factor receptor

Receptor tyrosine kinase

Cancer

Oncology

Epidermal growth factor

Lung cancer

Concomitant

Gefitinib

Tyrosine kinase

Cancer research

Medicine

JAMA Oncology

This cohort study examines the association of concomitant genetics alterations with response to treatment with epidermal growth factor receptor tyrosine kinase inhibitors among patients with EGFR-mutant advanced non–small cell lung cancer.

Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With <i>EGFR</i>-Mutant Advanced Non–Small Cell Lung Cancer

Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non–Small Cell Lung Cancer